NEW YORK (Reuters Health)—The risk of malignancy in patients with systemic necrotizing vasculitis varies according to the treatment received, according to an analysis of five randomized controlled trials. Previous studies reported an increased risk of malignancy in patients with systemic necrotizing vasculitis, and a more recent study from the European Vasculitis Study Group, based on…
Search results for: cancer
Male Researchers Call Their Work ‘Novel’ More Often Than Women
(Reuters Health)—Male scientists are more likely than their female counterparts to use superlatives, such as first or novel, to describe their work, a new study suggests, and this disparity might contribute to other professional gender gaps, the authors say. The study team analyzed the language used in more than 6 million papers in peer-reviewed medical…

The 2019 ACR Award Winners & Distinguished Fellows
ATLANTA—Every year at its Annual Meeting, the ACR recognizes its members’ outstanding contributions to the field of rheumatology through an awards program. The ACR is proud to announce 20 award recipients for 2019, honored for their accomplishments as clinicians, instructors or researchers who have helped advance rheumatology, for their commitment to inspire others to enter…

Meet the Incoming Arthritis & Rheumatology Editor in Chief, Dr. Daniel Solomon
Daniel Solomon, MD, MPH, has practiced rheumatology for more than 20 years, all while conducting translational and clinical research and teaching young clinicians. Soon, he will also step into the role of editor in chief of Arthritis & Rheumatology, as Richard J. Bucala, MD, PhD, ends his tenure. He will assume some duties during a…

Remote Use of the Multidimensional Health Assessment Questionnaire (MDHAQ)
The patient medical history is far more prominent in clinical decisions for rheumatology than for many common chronic diseases in which a gold standard biomarker, such as blood pressure or serum glucose, is applicable to diagnosis and management of all individual patients.1 Components of a subjective patient history may be recorded as structured, quantitative, standard,…

Spotlight on Ethics & Conflicts of Interest: A Conversation with Karen Onel, MD, New Chair of the ACR’s Ethics Committee
Karen Onel, MD, new chair of ACR’s Committee on Ethics & Conflict of Interest, brings a longstanding interest in issues related to ethics and consent.

Rituximab-abbs Available in the U.S.; Plus Upadacitinib in Phase 3 Trials for PsA
Rituximab-abbs, which is biosimilar to rituximab, is now available in the U.S. to treat specific cancers…
ACR Supports Bill to Establish Minimum DXA Payment
Legislation introduced in both houses of Congress would set a minimum Medicare reimbursement of $98 for DXA bone density scans.

Progress on Preventing Immune-Related Adverse Events
ATLANTA—One of the hottest topics in medicine is the emerging field of cancer immunotherapy. However, immune-related adverse events (irAEs) are associated with the therapy, and when things go wrong, they can go very, very wrong, said Ryan Sullivan, MD, during the 2019 ACR/ARP Annual Meeting in November. “The guiding principle of cancer immunotherapy is [that]…

ACR Survey Seeks to Better Define Conflicts of Interest
Recognizing that situations involving ties with the pharmaceutical industry and conflicts of interest are often not black and white, the ACR’s Committee on Ethics and Conflict of Interest has collected feedback on four ethically challenging scenarios to gauge how rheumatology providers think about them. The survey generated responses that were often mixed, showing that when…
- « Previous Page
- 1
- …
- 27
- 28
- 29
- 30
- 31
- …
- 86
- Next Page »